Product image of Medociprin (Ciprofloxacin) supplied by GNH India

Medociprin

Active Ingredient:
Ciprofloxacin
Origin:
EU

Medociprin (Ciprofloxacin)

Ciprofloxacin, the active ingredient in Medociprin, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a broad range of bacterial infections in adults and children when prescribed by a qualified healthcare professional. The drug is absorbed rapidly from the gastrointestinal tract and achieves therapeutic concentrations in urine, respiratory secretions, skin, and bone. It is indicated for infections caused by susceptible Gram‑negative and some Gram‑positive organisms. The formulation complies with European Union quality standards and is supplied under a prescription‑only status.
GNH India supplies Medociprin as a licensed, GDP‑compliant pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Medochemie Ltd.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ciprofloxacin is used to treat bacterial infections affecting various organ systems.
  • Urinary tract infection: eradicates susceptible bacteria and resolves urinary symptoms.
  • Respiratory tract infection: clears pathogens from the lower and upper airways, improving cough and fever.
  • Skin and soft tissue infection: eliminates causative organisms, promoting healing of cellulitis and wound infections.
  • Gastrointestinal infection: treats infections such as traveler's diarrhea caused by susceptible bacteria.
  • Bone and joint infection: penetrates bone tissue to control osteomyelitis and septic arthritis.

How It Works

  • Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these enzymes, it prevents the supercoiling and relaxation of DNA, leading to bacterial cell death. The drug exhibits bactericidal activity against a wide spectrum of Gram‑negative and some Gram‑positive organisms, making it effective for systemic infections when administered orally.

Side Effects

Ciprofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea
  • Diarrhea
  • Headache
  • Rash

Serious or Rare Side Effects

  • Tendon rupture or tendinitis
  • Peripheral neuropathy
  • Clostridioides difficile‑associated colitis
  • Severe allergic reactions such as anaphylaxis

Precautions & Warnings

  • Before prescribing Medociprin, clinicians should consider several safety measures.
  • Assess renal function: adjust dose in patients with impaired clearance.
  • Monitor for tendon pain: discontinue if signs of tendonitis appear.
  • Evaluate for QT prolongation: avoid in patients with cardiac arrhythmias.
  • Avoid use in children and pregnant women unless benefits outweigh risks.
  • Review concomitant medications: consider potential interactions with antacids and anticoagulants.
  • Store at room temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Ciprofloxacin can interact with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: reduce absorption of ciprofloxacin.
  • Warfarin: may increase anticoagulant effect, requiring INR monitoring.
  • Theophylline: increased plasma levels, risk of toxicity.
  • Cyclosporine: elevated levels, risk of nephrotoxicity.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of CNS stimulation.
  • Diabetic agents (e.g., insulin, sulfonylureas): may cause hypoglycemia.
  • Corticosteroids: increased risk of tendon rupture.
  • Oral contraceptives: may reduce efficacy, advise additional contraception.

Frequently Asked Questions

Medociprin, containing ciprofloxacin, is prescribed for a variety of bacterial infections such as uncomplicated urinary tract infections, community‑acquired respiratory tract infections, skin and soft‑tissue infections, certain gastrointestinal infections, and bone or joint infections caused by susceptible organisms.

Ciprofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition prevents bacterial cells from reproducing, leading to bacterial death and resolution of the infection.

The dosage of Medociprin is set by the prescribing clinician based on the type and severity of the infection, patient age, weight, renal function, and any relevant comorbidities. No fixed regimen is provided here.

Ciprofloxacin is classified as pregnancy category unknown in many regions, and its safety has not been fully established. It should only be used during pregnancy or lactation if the potential benefit justifies the potential risk to the fetus or infant.

To order Medociprin, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both ciprofloxacin and levofloxacin belong to the fluoroquinolone class and share a similar mechanism of action. Ciprofloxacin generally has broader activity against Gram‑negative organisms, while levofloxacin may offer enhanced coverage of certain Gram‑positive bacteria. Choice depends on the pathogen profile, infection site, patient tolerance and local resistance patterns.

Medociprin should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure they are out of reach of children.

Medociprin is taken orally, usually with a full glass of water. It may be taken with or without food, but should not be co‑administered with antacids containing magnesium or aluminum, as they can reduce absorption.

Serious risks include tendon rupture or tendinitis, peripheral neuropathy, Clostridioides difficile‑associated colitis, severe allergic reactions such as anaphylaxis, and QT‑interval prolongation that can lead to cardiac arrhythmias.

Medociprin should be avoided in patients with a known hypersensitivity to ciprofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, and individuals with significant cardiac arrhythmias or prolonged QT interval unless benefits outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ciprofloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT